Oculis (OCS) 10K Form and Latest SEC Filings 2026 $27.91 -0.05 (-0.18%) Closing price 04:00 PM EasternExtended Trading$28.26 +0.34 (+1.24%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Latest Oculis SEC Filings & Recent Activity Oculis (NASDAQ:OCS) has submitted 67+ documents to the U.S. Securities and Exchange Commission (SEC) since 2022. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Oculis's financial statements. The most recent filing was a Form 6-K submitted on May 14, 2026. 20-F Oculis Files Annual Report on Mar. 11, 2025The 20-F contains Oculis's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.View earnings history Oculis SEC Filing HistoryBrowse Oculis' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing. All Filing Types 10-K 10-Q 8-K 20-F 6-K 40-F 11-K 3 4 5 144 13F-HR SC 13D SC 13G DEF 14A DEFA14A S-1 S-3 S-4 S-8 F-1 424B2 425 D SD Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export DateFilerForm TypeView05/14/2026 3:05 PMOculis (1953530) FilerForm 6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 05/11/2026 3:05 PMOculis (1953530) FilerForm 6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 04/21/2026 3:10 PMOculis (1953530) FilerForm 6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 03/27/2026 5:30 AMBVCF IV, L.P. (1761158) Filed byOculis (1953530) SubjectForm SCHEDULE 13G/A03/09/2026 3:08 PMOculis (1953530) SubjectSherif Riad (2048639) ReportingForm 144Notice of proposed sale of securities pursuant to Rule 144 03/04/2026 3:19 PMOculis (1953530) FilerForm F-3ASR12/08/2025 11:15 PMOculis (1953530) FilerForm EFFECT12/01/2025 3:20 PMOculis (1953530) FilerForm 424B311/10/2025 3:49 PMOculis (1953530) FilerForm F-3Registration statement for securities of certain foreign private issuers 10/31/2025 4:20 PMOculis (1953530) FilerForm 424B510/31/2025 4:25 PMOculis (1953530) FilerForm 424B510/31/2025 3:55 PMOculis (1953530) FilerForm 6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 10/29/2025 4:17 PMOculis (1953530) FilerForm 6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 10/09/2025 3:22 PMACKERMANN CHRISTINA (1681871) ReportingOculis (1953530) SubjectForm 144Notice of proposed sale of securities pursuant to Rule 144 10/06/2025 3:40 PMOculis (1953530) FilerForm 6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 09/23/2025 3:56 PMOculis (1953530) SubjectSherif Riad (2048639) ReportingForm 144Notice of proposed sale of securities pursuant to Rule 144 08/21/2025 3:30 PMOculis (1953530) FilerForm 6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 08/01/2025 3:05 PMOculis (1953530) FilerForm 6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (Data available from 1/1/2016 forward) Oculis SEC Filings - Frequently Asked Questions How many times has Oculis filed with the SEC? Oculis (OCS) has submitted 67+ filings to the SEC since 2022. You can browse the complete history or filter by form type using the tools above. When does Oculis typically file its annual 10-K? Oculis's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Oculis's financial statements page. What was Oculis's most recent SEC filing? The most recent filing was a Form 6-K submitted on May 14, 2026. View the full filing using the link above. SEC Filing Types: 10-K, 10-Q, 8-K and More What are SEC filings and why do they matter to investors? SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position. Are SEC filings public information? Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts. What is the difference between a 10-K and a 10-Q? A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year. What is a 10-K annual report? The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries. What is a 10-Q quarterly report? An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news. What is an 8-K current report? Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events. What is a Form 4 insider ownership filing? Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements. Related Companies and Tools Related Companies Qiagen 10K Form Kymera Therapeutics 10K Form TG Therapeutics 10K Form Spyre Therapeutics 10K Form Protagonist Therapeutics 10K Form Mirum Pharmaceuticals 10K Form Rhythm Pharmaceuticals 10K Form CG Oncology 10K Form PTC Therapeutics 10K Form Lantheus 10K Form SEC Filings Tools Latest SEC Filings13F FilingsTop 13F BuysTop 13F SellsInsider Trading Activity This page (NASDAQ:OCS) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredIran War Update: Trump’s Hand-Written Letter Reveals What Comes NextJim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...Paradigm Press | SponsoredThis stock has 30 days of quiet leftA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | SponsoredThe Death of the Nasdaq?The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...Chaikin Analytics | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredThe $700 billion buy signal most investors are completely ignoringAmazon, Google, Meta, and Microsoft have committed $700 billion to AI infrastructure this year - more capital ...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.